|
|
| Research article summary (published 11 Oct 2009): |
The role of CACNA1S in predisposition to malignant hyperthermia.
Full Abstract
BACKGROUND: Malignant hyperthermia (MH) is an inherited pharmacogenetic disorder of skeletal muscle, characterised by an elevated calcium release from the skeletal muscle sarcoplasmic reticulum. The dihydropyridine receptor (DHPR) plays an essential role in excitation-contraction coupling and calcium homeostasis in skeletal muscle. This study focuses on the gene CACNA1S which encodes the alpha1 subunit of the DHPR, in order to establish whether CACNA1S plays a major role in MH susceptibility in the UK. METHODS: We investigate the CACNA1S locus in detail in 50 independent MH patients, the largest study to date, to identify novel variants that may predispose to disease and also to characterise the haplotype structure across CACNA1S. RESULTS: We present CACNA1S cDNA sequencing data from 50 MH patients in whom RYR1 mutations have been excluded, and subsequent mutation screening analysis. Furthermore we present haplotype analysis of unphased CACNA1S SNPs to (1) assess CACNA1S haplotype frequency differences between susceptible MH cases and a European control group and (2) analyse population-based association via clustering of CACNA1S haplotypes based on disease risk. CONCLUSION: The study identified a single potentially pathogenic change in CACNA1S (p.Arg174Trp), and highlights that the haplotype structure across CACNA1S is diverse, with a high degree of variability.
Author information
Author/s: Carpenter, Danielle (D); Ringrose, Christopher (C); Leo, Vincenzo (V); Morris, Andrew (A); Robinson, Rachel L (RL); Halsall, P Jane (PJ); Hopkins, Philip M (PM); Shaw, Marie-Anne (MA);
Affiliation: MH Investigation Unit, Academic Unit of Anaesthesia, St James's University Hospital, Leeds, LS9 7TF, UK. danielle.carpenter(-atsign-)nottingham.ac.uk
Journal and publication information
Publication Type: In Vitro; Journal Article; Research Support, Non-U.S. Gov't
Journal: BMC medical genetics (BMC Med Genet), published in England. (Language: eng)
Reference: 2009-; vol 10 (issue ) : pp 104
Dates: Created 2009/10/29; Completed 2009/10/30; Revised 2009/10/30;
PMID: 19825159, status: MEDLINE (last retrieval date: 11/2/2009, IMS Date: )
Sourced from the National Library of Medicine. Abstract text and other information may be subject to copyright.
External Links for this article
(including full text providers, if available):
Click Electronic Full-text Provider Links to see options for finding the electronic full text links to this article. Note there may be a subscription or fee required for access to the full text. See our FAQ for information on finding FREE full text articles.
This article may also be located in paper journal collections available in many libraries. Use the Journal and Publication Information above to find the full article.
MeSH headings (categories)
This article was linked to the MESH Headings shown below.
Related articles
These are the highest related articles currently in the database:
- Malignant hyperthermia susceptibility, an autosomal dominant disorder?
30 May 1997 - C1840-T mutation in the human skeletal muscle ryanodine receptor gene: frequency in northern German families susceptible to malignant hyperthermia and the relationship to in vitro contracture response.
30 Dec 1994 - Xenon does not induce contracture in human malignant hyperthermia muscle.
30 Oct 2000 - [Diagnosis of susceptibility for malignant hyperthermia using in-vitro muscle contraction testing in Switzerland]
18 Apr 1991 - The differential effect of halothane and 1,2-dichlorohexafluorocyclobutane on in vitro muscle contractures of patients susceptible to malignant hyperthermia.
30 Mar 2002 - Similar susceptibility to halothane, caffeine and ryanodine in vitro reflects pharmacogenetic variability of malignant hyperthermia.
30 Jan 2004 - Calcium release from sarcoplasmic reticulum is facilitated in human myotubes derived from carriers of the ryanodine receptor type 1 mutations Ile2182Phe and Gly2375Ala.
30 Dec 2002 - Genotype-phenotype comparison of the Swiss malignant hyperthermia population.
29 Sep 2001 - Between-center variability of results of the in vitro contracture test for malignant hyperthermia susceptibility.
30 Jul 2000 - Male preponderance of patients testing positive for malignant hyperthermia susceptibility.
29 Apr 2007
Related Article Map
Legend:
- FREE Full text Article.
- Abstract only.
- Title only. More help.
See a large map of 100+ related articles.